Fabbio Patrick
Insider CIK 1658859 · TARA Chief Financial Officer · BYSI Director · RFL Chief Financial Officer · PGNX CFO
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BYSI BeyondSpring Inc. | A Award deriv | 2026-04-01 | 2026-04-03 | 22,165 | — | $0 | 22,165 | SEC↗ |
| TARA Protara Therapeutics, Inc. | F Tax w/h | 2026-01-26 | 2026-01-27 | 3,261 | $6.67 | $21.8K | 64,115 | SEC↗ |
| TARA Protara Therapeutics, Inc. | F Tax w/h | 2026-01-20 | 2026-01-22 | 3,063 | $5.60 | $17.2K | 67,376 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2026-01-16 | 2026-01-21 | 175,000 | — | $0 | 175,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award | 2026-01-16 | 2026-01-21 | 28,000 | — | $0 | 70,439 | SEC↗ |
| BYSI BeyondSpring Inc. | A Award deriv | 2025-04-21 | 2025-04-23 | 23,793 | — | $0 | 23,793 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2025-01-24 | 2025-01-28 | 140,000 | — | $0 | 140,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award | 2025-01-24 | 2025-01-28 | 23,500 | — | $0 | 45,500 | SEC↗ |
| TARA Protara Therapeutics, Inc. | F Tax w/h | 2025-01-21 | 2025-01-23 | 3,061 | $4.76 | $14.6K | 18,939 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2024-01-19 | 2024-01-23 | 131,000 | — | $0 | 131,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award | 2024-01-19 | 2024-01-23 | 22,000 | — | $0 | 22,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2023-01-30 | 2023-01-30 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RFL Rafael Holdings, Inc. | F Tax w/h | 2022-12-21 | 2022-12-23 | 27,928 | $1.76 | $49.2K | 335,175 | SEC↗ |
| RFL Rafael Holdings, Inc. | A Award | 2022-02-01 | 2022-02-03 | 363,103 | — | $0 | 363,103 | SEC↗ |
| RFL Rafael Holdings, Inc. | A Award deriv | 2021-09-17 | 2021-09-20 | 105,602 | — | $0 | 105,602 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2020-03-02 | 2020-03-04 | 82,214 | — | $0 | 82,214 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2019-03-01 | 2019-03-05 | 90,750 | — | $0 | 90,750 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2018-03-01 | 2018-03-02 | 94,875 | — | $0 | 94,875 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2017-03-01 | 2017-03-07 | 82,500 | — | $0 | 82,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2016-03-01 | 2016-03-03 | 82,500 | $4.52 | $372.9K | 82,500 | SEC↗ |
| PGNX PROGENICS PHARMACEUTICALS | A Award deriv | 2015-12-01 | 2015-12-03 | 125,000 | $6.77 | $846.3K | 125,000 | SEC↗ |